Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS4 | O75173 | 3/20 | 0.77 |
| ▸ | ADAMTS5 | Q9UNA0 | 18/20 | 0.75 |
| ▸ | MMP2 | P08253 | 7/20 | 0.70 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.66 |
| ▸ | MMP13 | P45452 | 3/20 | 0.64 |
| ▸ | ADAMTS1 | Q9UHI8 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20708423 | 0.88 | ADAMTS5 (0.76) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL19691587 | 0.87 | ADAMTS4 (1.00) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL19691565 | 0.87 | ADAMTS5 (0.80) | ADAMTS4ADAMTS5MMP2ADAM17 | |
| SCHEMBL20708268 | 0.87 | ADAMTS5 (0.80) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL20708294 | 0.86 | ADAMTS5 (0.75) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL19691547 | 0.85 | ADAMTS5 (1.00) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL20708321 | 0.85 | MMP2 (0.77) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL22892307 | 0.84 | ADAMTS5 (0.78) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL20708307 | 0.84 | ADAMTS5 (0.76) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 | |
| SCHEMBL20708300 | 0.83 | MMP2 (0.78) | ADAMTS4ADAMTS5MMP2ADAM17MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3468955-B1 | 5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2021-01-06 | — | — | EP | disclosed |